Life sciences news
-
argenx reports topline results from ADVANCE-SC study of VYVGART Hytrulo in primary immune thrombocytopenia
Tuesday November 28th 2023
Read more
-
Biocartis Holdings Inc.: Recapitalization completed and product portfolio expansion
Wednesday November 22nd 2023
Read more
-
argenx announces European Commission approval of subcutaneous VYVGART® (efgartigimod alfa) for generalized myasthenia gravis
Thursday November 16th 2023
Read more
-
Introducing Pathomation's Cutting-Edge Digital Pathology Solution for clinical diagnostic Pathology labs: Pathomation Image Management and viewing Software (PIMS)
Wednesday November 15th 2023
Read more
-
Orionis Biosciences announces first patient dosed in Phase 1 clinical trial of ORB-011 in patients with advanced solid tumors
Wednesday November 15th 2023
Read more
-
SwiftPharma and PlantForm target blockbuster cancer drug with new contract manufacturing agreement for plant-made biosimilars
Tuesday November 14th 2023
Read more
-
VUB maps complexity of pancreatic tumours
Tuesday November 14th 2023
Read more
-
miDiagnostics announces collaboration with Galapagos to develop closed-flow, ultra-rapid CAR-T sterility test for its point-of-care CAR-T manufacturing platform
Friday November 10th 2023
Read more
-
Become a flanders.bio member
Your news here?
-
ACROBiosystems launches the world’s first GMP-grade DLL-4 Protein
Thursday November 9th 2023
Read more
-
Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to Alfasigma
Monday October 30th 2023
Read more
-
Mithra and Searchlight Pharma sign DONESTA® licensing agreement for Canada
Thursday October 26th 2023
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
